🇺🇸 FDA
Patent

US 11958901

Anti-CXCR5 antibodies and compositions and uses thereof

granted A61KA61K2039/54A61K2039/545

Quick answer

US patent 11958901 (Anti-CXCR5 antibodies and compositions and uses thereof) held by The Regents of the University of California expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
34
CPC classes
A61K, A61K2039/54, A61K2039/545, A61P, A61P19/02